Stay updated with breaking news from 37555810. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Matrix Asset Advisors Inc. NY lifted its stake in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 1.0% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 303,854 shares of the biopharmaceutical company’s stock after acquiring an additional 3,123 shares during the quarter. […]
Perkins Coie Trust Co boosted its position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 8,127.7% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 3,867 shares of the biopharmaceutical company’s stock after purchasing an additional 3,820 shares during the period. Perkins Coie […]
Kentucky Retirement Systems bought a new position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 96,689 shares of the biopharmaceutical company’s stock, valued at approximately $7,246,000. A number of other hedge funds and other institutional […]
Stonehearth Capital Management LLC bought a new position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 2,862 shares of the biopharmaceutical company’s stock, valued at approximately $214,000. Other large investors have […]
Stonehearth Capital Management LLC acquired a new position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) in the 3rd quarter, HoldingsChannel reports. The firm acquired 2,862 shares of the biopharmaceutical company’s stock, valued at approximately $214,000. Other hedge funds also recently modified their holdings of the company. PCA Investment Advisory Services Inc. acquired […]